Press Releases Bolt Biotherapeutics, Inc.

Stocks

BOLT

US0977022039

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 02:00:00 11/06/2026 am IST			5-day change	1st Jan Change
4.430 ^USD	-4.11%		-4.32%	-18.98%

13/05	Bolt Biotherapeutics reports first quarter 2026 financial results	RE
13/05	Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Press Releases

13/05	Bolt Biotherapeutics Inc.: Q1 Earnings Snapshot	AQ
13/05	Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update	AQ
18/04	Bolt Biotherapeutics : BDC-4182 AACR Poster (BBI-4182-101 TiP AACR 2026 Final)	PU
13/03	Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot	AQ
13/03	Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update	AQ
24/02	Bolt Biotherapeutics to Participate in Upcoming March Conferences	AQ
13/11	Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot	AQ
13/11	Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update	AQ
02/25/02	Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027	AQ
15/25/15	Bolt Biotherapeutics Inc.: Q2 Earnings Snapshot	AQ
15/25/15	Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update	AQ
13/25/13	Bolt Biotherapeutics : Presentation (2025-05-12-BOLT BDC-3042 Event)	PU
13/25/13	Bolt Biotherapeutics Inc.: Q1 Earnings Snapshot	AQ
13/25/13	Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update	GL
08/25/08	Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates	GL
08/25/08	Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates	AQ
01/25/01	Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025	GL
25/25/25	Bolt Biotherapeutics : PD-L1 AACR Poster (PDL1 AACR 2025 final print)	PU
25/25/25	Bolt Biotherapeutics : BDC 3042 AACR Poster (BDC 3042 AACR 2025 Poster v23Apr2025 Print)	PU
25/25/25	Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025	GL
21/25/21	Bolt Biotherapeutics : CEACAM5 AACR Poster (CEACAM5 2025 AACR poster FINAL)	PU
26/25/26	Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025	GL
25/25/25	Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update	GL
25/25/25	Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update	AQ
26/25/26	Bolt Biotherapeutics to Participate in Upcoming March Conferences	AQ